Analysis: Greg Stanton's sell of TCNNF (Trulieve Cannabis Corp.)
Assessment: Low signal
A large-scale divestment of a volatile cannabis stock executed three weeks after major regulatory timelines became public, by a member with zero relevant committee oversight.
- Member: Greg Stanton
- Party / state: D-AZ
- Chamber: House
- Transaction: Sell
- Amount: $100,001 - $250,000
- Ticker: TCNNF
- Company: Trulieve Cannabis Corp.
- Trade date: 2026-05-28
- Disclosure date: 2026-06-26
- Disclosure lag: 29 days
Executive summary
Greg Stanton (D-AZ, House) reported a sale of Trulieve Cannabis Corp. (TCNNF) on 2026-05-28 in the range of $100,001–$250,000; it was disclosed on 2026-06-26 (29-day lag). In the user-provided trading history, Stanton has only two lifetime trades, both TCNNF sales (2026-05-06 and 2026-05-28). SEC filings around this period include a May 7, 2026 8-K furnishing an earnings release that references marijuana scheduling and DEA registration applications, and multiple June 2026 8-Ks (including a share repurchase authorization) plus June 2026 CEO Form 4 sales.
Per the user-provided dataset, Stanton’s trading activity is limited to two transactions over a short period (2026-05-06 to 2026-05-28), both sales of the same issuer (TCNNF) and owned by the member. The trade under analysis is the larger of the two sales by disclosed dollar range. In issuer disclosures, Trulieve filed an 8-K on 2026-05-07 (press release furnished as Exhibit 99.1) describing Q1 2026 results and including references to federal scheduling/regulatory process (including mention of medical marijuana being reclassified to Schedule III, an expedited review process with a hearing beginning 2026-06-29, and that Trulieve filed DEA registration applications for state-licensed operations). After the 2026-05-28 sale, Trulieve filed additional 8-Ks in June 2026 including disclosure of agreements relating to deconsolidation of a former subsidiary (reported date 2026-06-03; filed 2026-06-04), authorization of a share repurchase program (reported 2026-06-09), and a leadership change (reported 2026-06-11; filed 2026-06-12). In the Form 4 window provided, the CEO reported multiple sales transactions in mid-to-late June 2026 (with Form 4 filings dated 2026-06-22, 2026-06-25, and 2026-06-26).
Timeline
- 2026-02-27 — Trulieve 8-K (Item 5.02, 9.01) reporting termination of Chief Accounting Officer (leadership transition).
- 2026-03-05 — Filing date of the February 27, 2026 8-K (accession 0001754195-26-000021).
- 2026-04-15 — Trulieve 8-K (Item 5.02) stating a director will not stand for reelection at the June 9, 2026 annual meeting.
- 2026-04-21 — Filing date of the April 15, 2026 8-K (accession 0001754195-26-000023).
- 2026-05-06 — Greg Stanton reported sale of TCNNF ($15,001-$50,000) (member trading history provided by user).
- 2026-05-07 — Trulieve 8-K (Items 2.02, 7.01, 9.01) furnishing Q1 2026 results press release and investor presentation.
- 2026-05-07 — Q1 2026 earnings release exhibit includes: 'The Trump Administration reclassified medical marijuana to Schedule III under the Controlled Substances Act' and notes an 'expedited process' and 'a hearing beginning on June 29, 2026'; it also states the company 'Filed applications to register ... with the Drug Enforcement Agency.'
- 2026-05-28 — Greg Stanton sale of TCNNF ($100,001-$250,000) (trade analyzed).
- 2026-06-03 — Trulieve 8-K (Items 1.01, 2.01, 9.01) describing agreements to facilitate deconsolidation of former subsidiary Harvest Enterprises, LLC from financial statements.
- 2026-06-04 — Filing date of the June 3, 2026 8-K (accession 0001754195-26-000033).
- 2026-06-09 — Trulieve 8-K (Items 8.01, 9.01) announcing board authorization of share repurchase program (press release exhibit).
- 2026-06-09 — Press release exhibit states repurchase program up to lesser of (i) $50 million and (ii) 8,495,038 shares (5% of issued and outstanding subordinate voting shares as at June 8, 2026) over 12 months; expires June 16, 2027.
Independent analysis of public financial disclosures. Not financial or investment advice.